Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Corneal epithelialization after PRK using sodium hyaluronate/dexpanthenol preservative free eye drops

Poster Details

First Author: A. Dukić CROATIA

Co Author(s):    I. Dekaris   N. Milicic                 

Abstract Details

Purpose:

Evaluate the effect of sodium hyaluronate (0,15%) / dexpanthenol (2%) preservative free eye drops vs sodium hyaluronate (0,15%) artificial tears with preservative on corneal epithelial healing after photorefractive keratectomy (PRK) for correction of myopic and myopic-astigmatic defects . Efficacy was the evolution of corneal re-epithelialization.

Setting:

Specialty Eye Hospital, Svjetlost, Croatia

Methods:

40 eyes were enrolled in the study, randomly allocated into standard therapy plus sodium hyaluronate (0,15%) artificial tears with preservative - AT (20 eyes), or standard therapy plus sodium hyaluronate (0,15%) / dexpanthenol (2%) preservative free eye drops – Bepanthol, Bayer (20 eyes). Checks were carried out preoperatively and at days 1, 3, and 5 of the follow-up. Six eyes dropped out (four in Bepanthol group, two in AT group) for reasons unrelated to the study.

Results:

On first day the diameter of disepithelialized area was 8.125 mm+/- 0,9 (mean+/-SD) in AT and 8,08 mm +/- 0,28 in Bepanthol group. On day 3 a complete corneal re-epithelialization was found in 12 out of 16 (75%) eyes of Bepanthol group and in 11 out of 18 (61%) eyes of AT. On day 5 of follow-up, all eyes appeared to be completely re-epithelialized.

Conclusions:

The data of the study have shown that after PRK, Bepanthol stimulates corneal epithelium regeneration. Bepanthol administration six times a day is well tolerated by patients during the re-epithelialization stage. A much larger clinical study should be performed in order to prove the results obtained in this pilot study.

Financial Disclosure:

NONE

Back to Poster listing